La traduction de cette page est expérimentale et en cours de développement. N'hésitez pas à vos !
Eyebright Medical Technology (Beijing) Croissance future
Future contrôle des critères 5/6
Eyebright Medical Technology (Beijing) is forecast to grow earnings and revenue by 27.2% and 28.8% per annum respectively. EPS is expected to grow by 26.4% per annum. Return on equity is forecast to be 17.7% in 3 years.
Informations clés
27.2%
Taux de croissance des bénéfices
26.4%
Taux de croissance du BPA
| Medical Equipment croissance des bénéfices | 22.5% |
| Taux de croissance des recettes | 28.8% |
| Rendement futur des capitaux propres | 17.7% |
| Couverture par les analystes | Good |
| Dernière mise à jour | 11 Jun 2024 |
Mises à jour récentes de la croissance future
Recent updates
Returns Are Gaining Momentum At Eyebright Medical Technology (Beijing) (SHSE:688050)
Jul 15
Eyebright Medical Technology (Beijing) Co., Ltd.'s (SHSE:688050) 55% Price Boost Is Out Of Tune With Earnings
Jun 10Is Eyebright Medical Technology (Beijing) (SHSE:688050) Using Too Much Debt?
May 13Eyebright Medical Technology (Beijing)'s (SHSE:688050) Profits May Not Reveal Underlying Issues
Apr 24Eyebright Medical Technology (Beijing) Co., Ltd. Just Recorded A 22% Revenue Beat: Here's What Analysts Think
Apr 21Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050) May Have Run Too Fast Too Soon With Recent 26% Price Plummet
Mar 25A Look At The Fair Value Of Eyebright Medical Technology (Beijing) Co., Ltd. (SHSE:688050)
Mar 18Returns On Capital Are Showing Encouraging Signs At Eyebright Medical Technology (Beijing) (SHSE:688050)
Mar 01Prévisions de croissance des bénéfices et des revenus
| Date | Recettes | Les revenus | Flux de trésorerie disponible | Cash from Op | Moy. Nombre d'analystes |
|---|---|---|---|---|---|
| 12/31/2026 | 2,406 | 690 | 602 | 647 | 5 |
| 12/31/2025 | 1,882 | 532 | 360 | 474 | 6 |
| 12/31/2024 | 1,384 | 394 | 132 | 316 | 5 |
| 3/31/2024 | 1,072 | 328 | -208 | 239 | N/A |
| 12/31/2023 | 951 | 304 | -158 | 213 | N/A |
| 9/30/2023 | 806 | 287 | -79 | 175 | N/A |
| 6/30/2023 | 713 | 272 | -76 | 200 | N/A |
| 3/31/2023 | 638 | 252 | -25 | 236 | N/A |
| 12/31/2022 | 579 | 233 | -21 | 250 | N/A |
| 9/30/2022 | 549 | 229 | -51 | 280 | N/A |
| 6/30/2022 | 500 | 203 | -58 | 255 | N/A |
| 3/31/2022 | 480 | 194 | -71 | 230 | N/A |
| 12/31/2021 | 433 | 171 | -92 | 219 | N/A |
| 9/30/2021 | 416 | 168 | -10 | 217 | N/A |
| 6/30/2021 | 376 | 150 | 17 | 201 | N/A |
| 3/31/2021 | 331 | 129 | -19 | 160 | N/A |
| 12/31/2020 | 273 | 97 | 5 | 123 | N/A |
| 9/30/2020 | 237 | 86 | -9 | 83 | N/A |
| 6/30/2020 | 204 | 68 | -23 | 43 | N/A |
| 3/31/2020 | 178 | 53 | -93 | 44 | N/A |
| 12/31/2019 | 195 | 67 | -91 | 50 | N/A |
| 12/31/2018 | 127 | 20 | -40 | 32 | N/A |
| 12/31/2017 | 75 | -4 | N/A | 4 | N/A |
Prévisions de croissance des analystes
Taux de revenus par rapport au taux d'épargne: 688050's forecast earnings growth (27.2% per year) is above the savings rate (2.9%).
Bénéfices vs marché: 688050's earnings (27.2% per year) are forecast to grow faster than the CN market (21.9% per year).
Croissance élevée des bénéfices: 688050's earnings are expected to grow significantly over the next 3 years.
Chiffre d'affaires vs marché: 688050's revenue (28.8% per year) is forecast to grow faster than the CN market (13.4% per year).
Croissance élevée des revenus: 688050's revenue (28.8% per year) is forecast to grow faster than 20% per year.
Prévisions de croissance du bénéfice par action
Rendement futur des capitaux propres
ROE futur: 688050's Return on Equity is forecast to be low in 3 years time (17.7%).